NHC · National Healthcare Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $381.82M | - | $382.66M | $374.91M | $373.70M | - | $340.20M | $300.66M | $297.18M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $5.84M | - | $6.25M | $7.03M | $6.63M | - | $6.29M | $7.23M | $6.16M | - |
| Total Operating Expenses | $349.57M | - | $352.28M | $340.82M | $342.93M | - | $319.15M | $278.14M | $281.55M | - |
| D&A | $11.61M | - | $11.16M | $11.02M | $10.98M | - | $10.62M | $9.34M | $10.59M | - |
| Operating Income | $32.25M | - | $30.38M | $34.09M | $30.77M | - | $21.05M | $22.52M | $15.63M | - |
| Interest Expense | $269.0K | - | $1.74M | $0 | $46.0K | - | $1.74M | $0 | $46.0K | - |
| Income Tax | $8.71M | - | $13.40M | $8.05M | $11.43M | - | $15.34M | $9.49M | $9.46M | - |
| Net Income | $35.86M | - | $39.24M | $23.72M | $32.20M | - | $42.79M | $26.84M | $26.21M | - |
| EPS - Basic | $2.31 | - | $2.53 | $1.53 | $2.09 | - | $2.78 | $1.74 | $1.71 | - |
| EPS - Diluted | $2.27 | - | $2.50 | $1.52 | $2.07 | - | $2.73 | $1.73 | $1.69 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85.53M | $92.83M | $130.63M | $110.99M | $90.39M | $76.12M | $84.81M | $136.21M | $93.98M | $107.08M |
| Accounts Receivable | $137.74M | $139.00M | $132.45M | $142.06M | $141.74M | $135.32M | $128.78M | $109.39M | $125.66M | $108.55M |
| Inventory | $9.15M | $7.79M | $7.84M | $7.89M | $8.08M | $9.04M | $7.84M | $6.63M | $6.76M | $7.39M |
| Accounts Payable | $21.37M | $22.77M | $22.57M | $21.28M | $21.65M | $25.49M | $22.72M | $21.78M | $20.70M | $19.19M |
| Current Assets | $465.58M | $461.82M | $493.52M | $463.23M | $455.20M | $424.41M | $445.73M | $447.87M | $417.59M | $406.24M |
| Total Assets | $1.52B | $1.53B | $1.57B | $1.56B | $1.55B | $1.52B | $1.56B | $1.34B | $1.32B | $1.31B |
| Current Liabilities | $250.82M | $253.63M | $282.36M | $268.75M | $239.22M | $234.80M | $247.95M | $216.94M | $206.43M | $214.48M |
| Long-term Debt | $0 | $32.50M | $65.63M | $102.50M | $126.50M | $129.50M | $139.50M | - | - | - |
| Total Liabilities | $427.48M | $451.90M | $513.91M | $536.84M | $540.84M | $541.27M | $575.91M | $391.85M | $393.13M | $400.32M |
| Stockholders' Equity | $1.09B | $1.07B | $1.05B | $1.02B | $1.00B | $980.16M | $983.47M | $945.82M | $924.75M | $908.75M |
| Retained Earnings | $858.85M | $832.98M | $818.08M | $788.77M | $774.95M | $752.19M | $755.53M | $722.16M | $704.73M | $687.60M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $62.53M | - | - | - | $39.26M | - | - | - | $9.65M | - |
| Investing Cash Flow | ($13.89M) | - | - | - | ($7.32M) | - | - | - | ($2.42M) | - |
| Financing Cash Flow | ($54.50M) | - | - | - | ($12.69M) | - | - | - | ($12.07M) | - |
| CapEx | $9.64M | - | - | - | $6.14M | - | - | - | $5.96M | - |
| Free Cash Flow | $52.89M | - | - | - | $33.12M | - | - | - | $3.69M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 8.4% | - | 7.9% | 9.1% | 8.2% | - | 6.2% | 7.5% | 5.3% | - |
| EBITDA margin | 11.5% | - | 10.9% | 12.0% | 11.2% | - | 9.3% | 10.6% | 8.8% | - |
| Net margin | 9.4% | - | 10.3% | 6.3% | 8.6% | - | 12.6% | 8.9% | 8.8% | - |
| Free cash flow margin | 13.9% | - | - | - | 8.9% | - | - | - | 1.2% | - |
| FCF / Net income | 1.48 | - | - | - | 1.03 | - | - | - | 0.14 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 1.5% | - | 1.6% | 1.9% | 1.8% | - | 1.8% | 2.4% | 2.1% | - |
| Effective tax rate | 19.5% | - | 25.5% | 25.3% | 26.2% | - | 26.4% | 26.1% | 26.5% | - |
| Return on assets | 2.4% | - | 2.5% | 1.5% | 2.1% | - | 2.7% | 2.0% | 2.0% | - |
| Return on equity | 3.3% | - | 3.7% | 2.3% | 3.2% | - | 4.4% | 2.8% | 2.8% | - |
| Return on invested capital | 2.4% | - | 2.0% | 2.3% | 2.0% | - | 1.4% | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.86 | 1.82 | 1.75 | 1.72 | 1.90 | 1.81 | 1.80 | 2.06 | 2.02 | 1.89 |
| Quick ratio | 1.82 | 1.79 | 1.72 | 1.69 | 1.87 | 1.77 | 1.77 | 2.03 | 1.99 | 1.86 |
| Cash ratio | 0.34 | 0.37 | 0.46 | 0.41 | 0.38 | 0.32 | 0.34 | 0.63 | 0.46 | 0.50 |
| Leverage | ||||||||||
| Debt / Equity | 0.00 | 0.03 | 0.06 | 0.10 | 0.13 | 0.13 | 0.14 | - | - | - |
| Debt / Assets | 0.00 | 0.02 | 0.04 | 0.07 | 0.08 | 0.08 | 0.09 | - | - | - |
| Debt / EBITDA | 0.00 | - | 1.58 | 2.27 | 3.03 | - | 4.41 | - | - | - |
| Interest coverage | 119.9x | - | 17.4x | - | 668.8x | - | 12.1x | - | 339.8x | - |
| Equity multiplier | 1.40 | 1.43 | 1.49 | 1.53 | 1.54 | 1.56 | 1.59 | 1.42 | 1.43 | 1.44 |
| Liabilities / Assets | 0.28 | 0.30 | 0.33 | 0.34 | 0.35 | 0.36 | 0.37 | 0.29 | 0.30 | 0.31 |
| Efficiency | ||||||||||
| Asset turnover | 0.25 | - | 0.24 | 0.24 | 0.24 | - | 0.22 | 0.22 | 0.23 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 132d | - | 126d | 138d | 138d | - | 138d | 133d | 154d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 70.4x | - | 48.6x | 70.4x | 44.8x | - | 46.1x | 62.7x | 55.9x | - |
| P / B | 2.3x | - | 1.8x | 1.6x | 1.4x | - | 2.0x | 1.8x | 1.6x | - |
| P / S | 6.6x | - | 5.0x | 4.5x | 3.9x | - | 5.8x | 5.6x | 4.9x | - |
| EV / EBITDA | 55.5x | - | 44.3x | 36.8x | 35.5x | - | 64.0x | 48.7x | 52.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 2.2% | - | 12.5% | 24.7% | 25.7% | - | 17.9% | 6.4% | 10.2% | - |
| Revenue CAGR (3y) | 12.3% | - | 12.2% | 11.4% | 10.2% | - | 7.1% | 4.5% | 5.8% | - |
| Revenue CAGR (5y) | 8.8% | - | 8.8% | 7.5% | 7.8% | - | 6.6% | 4.0% | 3.7% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 4.8% | - | 44.3% | 51.4% | 96.9% | - | 61.6% | 61.1% | 56.1% | - |
| Net income growth (YoY) | 11.3% | - | -8.3% | -11.6% | 22.9% | - | 311.9% | 64.9% | 123.6% | - |
| EPS growth (YoY) | 9.7% | - | -8.4% | -12.1% | 22.5% | - | 301.5% | 63.2% | 122.4% | - |
| EPS CAGR (3y) | 44.0% | - | - | 93.4% | 27.9% | - | - | -36.6% | 7.0% | - |
| EPS CAGR (5y) | 10.5% | - | 24.4% | -3.7% | - | - | 16.5% | 14.2% | 4.0% | - |
| FCF growth (YoY) | 59.7% | - | - | - | 797.3% | - | - | - | -48.9% | - |
| FCF CAGR (5y) | 45.0% | - | - | - | 96.7% | - | - | - | -8.4% | - |
| Book value growth (YoY) | 8.6% | 9.0% | 7.1% | 8.0% | 8.7% | 7.9% | 11.1% | 7.0% | 5.4% | 3.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.47B totalInpatient Services Segment$1.32B · 89.5%
Homecare Services Segment$154.09M · 10.5%
Peer comparison
Same SIC group: Services-Skilled Nursing Care Facilities
Comparing NATIONAL HEALTHCARE CORP against the 3 most active filers in the same SIC group.
Dividends
$2.56/share trailing 12 months · +4.9% YoY
| Ex-date | Per share |
|---|---|
| Mar 31, 2026 | $0.6400 |
| Dec 31, 2025 | $0.6400 |
| Sep 30, 2025 | $0.6400 |
| Jun 30, 2025 | $0.6400 |
| Mar 28, 2025 | $0.6100 |
| Dec 30, 2024 | $0.6100 |
| Sep 30, 2024 | $0.6100 |
| Jun 28, 2024 | $0.6100 |
| Mar 27, 2024 | $0.5900 |
| Dec 28, 2023 | $0.5900 |
| Sep 28, 2023 | $0.5900 |
| Jun 29, 2023 | $0.5900 |
| Mar 30, 2023 | $0.5700 |
| Dec 29, 2022 | $0.5700 |
| Sep 29, 2022 | $0.5700 |
| Jun 29, 2022 | $0.5700 |
| Mar 30, 2022 | $0.5500 |
| Dec 30, 2021 | $0.5500 |
| Sep 29, 2021 | $0.5200 |
| Jun 29, 2021 | $0.5200 |
| Mar 30, 2021 | $0.5200 |
| Dec 30, 2020 | $0.5200 |
| Sep 29, 2020 | $0.5200 |
| Jun 29, 2020 | $0.5200 |